Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2011; 17(6): 735-742
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.735
Table 2 Comparison of prevalence of metabolic syndrome and its components among three groups
Group 0 (n = 274)NAFLD
Group 1 (n = 436)Group 2 (n = 151)
Age (yr)10.36 ± 2.1510.59 ± 1.8510.40 ± 2.28
Sex (M/F)187/87305/131106/45
Tanner stage (T1/T2–4)130/144209/22774/77
BMI26.88 ± 3.1928.78 ± 3.96a28.85 ± 3.69a
Hypertension68 (24.82)180 (41.28)a73 (48.34)a
Dyslipidemia42 (15.32)204 (46.78)a116 (76.82)ac
Impaired fasting glucose5 (1.82)30 (6.88)20 (13.24)ac
IGT13 (4.74)38 (8.72)18 (11.92)a
Diabetes0 (0.00)5 (1.14)7 (4.63)ac
MS33 (12.04)128 (29.36)a60 (39.74)ac